Article
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
2025-04-28
Abstract excerpt
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification. This review provides an overview of recent advancements in the application of CRISPR/...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e291cce5-00d6-596c-b32d-175763228897
- DOI
- 10.1002/viw.20250002
